Process for preparing a titanium-containing zeolitic material having an mww framework structure
US-2015368115-A1 · Dec 24, 2015 · US
US9663380B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9663380-B2 |
| Application number | US-201514884845-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 16, 2015 |
| Priority date | Oct 16, 2015 |
| Publication date | May 30, 2017 |
| Grant date | May 30, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A new crystalline molecular sieve designated SSZ-105 is disclosed. SSZ-105 is synthesized using N,N-dimethylpiperidinium cations as a structure directing agent. SSZ-105 is a disordered aluminosilicate molecular sieve comprising at least one intergrown phase of an ERI framework type molecular sieve and an LEV framework type molecular sieve.
Opening claim text (preview).
The invention claimed is: 1. An aluminosilicate molecular sieve composition having a SiO 2 /Al 2 O 3 mole ratio of from 10 to 50 comprising at least one intergrown phase comprising an ERI framework type molecular sieve and an LEV framework type molecular sieve. 2. The molecular sieve composition of claim 1 , having a SiO 2 /Al 2 O 3 mole ratio of from 10 to 25. 3. The molecular sieve composition of claim 1 , wherein the ERI framework type molecular sieve is present in the at least one intergrown phase in a proportion to the LEV framework type molecular sieve of from 5% to 95%, as determined by DIFFaX analysis. 4. The molecular sieve composition of claim 1 , wherein the ERI framework type molecular sieve is present in the at least one intergrown phase in a proportion to the LEV framework type molecular sieve of from 10% to 90%, as determined by DIFFaX analysis. 5. The molecular sieve composition of claim 1 , wherein the ERI framework type molecular sieve is present in the at least one intergrown phase in a proportion to the LEV framework type molecular sieve of from 20% to 80%, as determined by DIFFaX analysis. 6. The molecular sieve composition of claim 1 , wherein the ERI framework type molecular sieve is present in the at least one intergrown phase in a proportion to the LEV framework type molecular sieve of from 30% to 70%, as determined by DIFFaX analysis. 7. The molecular sieve composition of claim 1 , wherein the ERI framework type molecular sieve is present in the at least one intergrown phase in a proportion to the LEV framework type molecular sieve of from 40% to 60%, as determined by DIFFaX analysis.
using at least one organic template directing agent · CPC title
Erionite or offretite type, e.g. zeolite T · CPC title
using at least one organic template directing agent · CPC title
Preparation of physical mixtures or intergrowth products of zeolites chosen from group C01B39/04 or two or more of groups C01B39/14 - C01B39/48 · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.